Cookie Policy - To find out more about cookies on this website, see our privacy policy

Cookie Policy

We Help Companies Find New Sales Opportunities

We Help Companies Find New Sales Opportunities


Provalis is to sell its medical diagnostics business to Bio-Metrics UK for £1.6m, and the remaining company will be placed into members' voluntary liquidation.

Provalis is to sell most of its Provalis Healthcare division to the Kogen affiliate of Galen for about £10m, in order to focus on medical diagnostics.

Provalis has secured a £1m Welsh Assembly grant to expand production of medical testing kits at its Deeside factory.

Provalis is raising £10m in a share placing to fund the development of products based on derivatives of its Glycosal monitor for diabetes.

Provalis, the distributor of medical devices and pharmaceutical products, is to set up a new 11,000 sq ft warehouse and production facility near its Deeside headquarters in September.

Provalis is to raise £11m in a share placing, in order to fund the expansion of its Glycosal diabetes monitoring device.